Nisa Investment Advisors
CLYM

Nisa Investment Advisors’s Climb Bio CLYM Stock Holding History

Nisa Investment Advisors’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.47K Hold
573
– – ﹤0.01% 2540
2026
Q1 		$3.92K Hold
573
– – ﹤0.01% 2511
2025
Q4 		$2.29K Hold
573
– – ﹤0.01% 2588
2025
Q3 		$1.15K Hold
573
– – ﹤0.01% 2715
2025
Q2 		$711 Buy
+573
New +$713 ﹤0.01% 2806
2025
Q1 		– Sell
-227
Closed -$409 – 3071
2024
Q4 		$409 Buy
+227
New +$821 ﹤0.01% 2865

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nisa Investment Advisors's CLYM Position: Q2 2026 in Review

Nisa Investment Advisors held its Climb Bio (CLYM) position steady in Q2 2026 at 573 shares worth $7.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

Nisa Investment Advisors first reported a position in CLYM in Q4 2024 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Nisa Investment Advisors held 573 shares of Climb Bio worth $7.47K as of Q2 2026.
  • Nisa Investment Advisors left its Climb Bio share count unchanged in Q2 2026.
  • Climb Bio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2540 holding.
  • Nisa Investment Advisors first reported a position in Climb Bio in Q4 2024 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.